Compound, pharmaceutical composition, methods for treating or preventing cardiovascular disease, dyslipidemia, dyslipoproteinemia, glucose metabolism disorder, thrombotic and associated with peroxisome proliferator activated receptor, alzheimer's disease, x syndrome or metabolic syndrome , septicemia, obesity, pancreatitis, hypertension, kidney disease, cancer, inflammation and impotence, in a patient and to reduce the fat content of poultry eggs and poultry meat

摘要

"COMPOSITION, PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING OR PREDICTING CARDIOVASCULAR DISEASE, DYSLIPIDEMIA, DYSLIPOPROTEINEMIA, A DISEASE OF THE GLYDOS METABOLISM, RECEIVED WITH THE AXIS OF THE AEROSIS OF THE AXIS, DYNAMICS OF THE CARE METABOLICS, SEPTICEMIA, OBESITY, PANCREATITIS, HYPERTENSION, KIDNEY DISEASE, CANCER, INFLAMMATION AND IMPOTENCE, IN A PATIENT AND TO REDUCE THE FAT CONTENT OF BREEDING AND DUCKING DUCK. The present invention relates to novel sulfide and disulfide compounds, compositions comprising sulfide and disulfide compounds and methods useful for treating and preventing cardiovascular disease, dyslipidemia, dysproteinemia and glucose metabolism disorders comprising administering a composition comprising an ether compound. The compounds, compositions and methods of the invention are also useful for treating and preventing Alzheimer's disease, Syndrome X, peroxisome proliferator activated receptor related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, kidney disease, cancer, inflammation. and impotence. In certain embodiments, the compounds, compositions and methods of the invention are useful in combination therapy with other therapeutic products such as hypocholesterolemic and hypoglycemic agents.